Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States

INTRODUCTION: The National Health and Nutrition Examination Surveys show that many people with type 2 diabetes (T2D) in the USA fail to achieve recommended treatment targets. In the SUSTAIN 7 randomized controlled trial, once-weekly semaglutide (0.5 and 1.0 mg) was superior to comparative doses of d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Wilkinson, Lars, Hunt, Barnaby, Johansen, Pierre, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984908/
https://ncbi.nlm.nih.gov/pubmed/29557057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-018-0402-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars